| scholarly article | Q13442814 |
| P50 | author | Ewa Koscielniak | Q114726846 |
| Christopher Poremba | Q1086901 | ||
| P2093 | author name string | Angelika Eggert | |
| Martin Eisenacher | |||
| Uta Dirksen | |||
| Michaela Nathrath | |||
| Georg Gosheger | |||
| Dominik T Schneider | |||
| Helmut E Gabbert | |||
| Heribert Juergens | |||
| Claudia Lanvers-Kaminsky | |||
| Daniel H Wai | |||
| David Herrero | |||
| Yvonne Braun | |||
| Karl-Ludwig Schaefer | |||
| Sabine Stegmaier | |||
| Carsten Bury | |||
| Laura Ottaviano | |||
| Kristin Brachwitz | |||
| Raihanatou Diallo-Danebrock | |||
| P433 | issue | 5 | |
| P304 | page(s) | 699-709 | |
| P577 | publication date | 2008-02-21 | |
| P1433 | published in | European Journal of Cancer | Q332260 |
| P1476 | title | Microarray analysis of Ewing's sarcoma family of tumours reveals characteristic gene expression signatures associated with metastasis and resistance to chemotherapy | |
| P478 | volume | 44 |
| Q37165799 | A molecular function map of Ewing's sarcoma |
| Q33381646 | A novel gene signature for molecular diagnosis of human prostate cancer by RT-qPCR. |
| Q38760598 | Activation of Wnt/β-Catenin in Ewing Sarcoma Cells Antagonizes EWS/ETS Function and Promotes Phenotypic Transition to More Metastatic Cell States |
| Q52370039 | Anti-mitotic chemotherapeutics promote apoptosis through TL1A-activated death receptor 3 in cancer cells. |
| Q35882212 | Apoptosis resistance and PKC signaling: distinguishing features of high and low metastatic cells |
| Q34635079 | BCL11B is up-regulated by EWS/FLI and contributes to the transformed phenotype in Ewing sarcoma |
| Q39282601 | BIRC5 expression is a poor prognostic marker in Ewing sarcoma |
| Q38352962 | Biological indicators of prognosis in Ewing's sarcoma: an emerging role for lectin galactoside-binding soluble 3 binding protein (LGALS3BP). |
| Q26777117 | Cancer Bioinformatic Methods to Infer Meaningful Data From Small-Size Cohorts |
| Q39215865 | Characterization of Ewing sarcoma associated cancer/testis antigens |
| Q43258817 | Critical signaling pathways in bone sarcoma: candidates for therapeutic interventions |
| Q37335373 | Diagnostic and prognostic sarcoma signatures |
| Q39325942 | Downstream EWS/FLI1 - upstream Ewing's sarcoma |
| Q36888312 | Dual Pten/Tp53 suppression promotes sarcoma progression by activating Notch signaling |
| Q92492912 | EWS-FLI1 modulated alternative splicing of ARID1A reveals novel oncogenic function through the BAF complex |
| Q37135628 | EWS-FLI1 suppresses NOTCH-activated p53 in Ewing's sarcoma |
| Q35987417 | Endoplasmic reticulum targeting in Ewing's sarcoma by the alkylphospholipid analog edelfosine |
| Q34949575 | EphA2-induced angiogenesis in ewing sarcoma cells works through bFGF production and is dependent on caveolin-1. |
| Q98613150 | Ewing sarcoma family of tumors-derived small extracellular vesicle proteomics identify potential clinical biomarkers |
| Q82884131 | Ewing's sarcoma |
| Q33808340 | Ewing's sarcoma precursors are highly enriched in embryonic osteochondrogenic progenitors |
| Q37522056 | Ewing's sarcoma: standard and experimental treatment options |
| Q39177112 | First identification of Ewing's sarcoma-derived extracellular vesicles and exploration of their biological and potential diagnostic implications. |
| Q37152828 | GLI1 is a direct transcriptional target of EWS-FLI1 oncoprotein. |
| Q35688154 | Gene Expression Profiling of Ewing Sarcoma Tumors Reveals the Prognostic Importance of Tumor-Stromal Interactions: A Report from the Children's Oncology Group |
| Q37468623 | Gene expression profiling for the investigation of soft tissue sarcoma pathogenesis and the identification of diagnostic, prognostic, and predictive biomarkers |
| Q37351875 | Gene expression profiling of canine osteosarcoma reveals genes associated with short and long survival times. |
| Q33992622 | Gene expression profiling of peripheral blood cells: new insights into Ewing sarcoma biology and clinical applications |
| Q37616100 | Genomic expression, chemotherapy response, and molecular targets in soft tissue sarcomas of the extremities: promising strategies for treatment selection |
| Q35972073 | Glutathione s-transferases in pediatric cancer |
| Q42106350 | Histone deacetylase inhibitors enhance expression of NKG2D ligands in Ewing sarcoma and sensitize for natural killer cell-mediated cytolysis |
| Q37589156 | Hypoxia shifts activity of neuropeptide Y in Ewing sarcoma from growth-inhibitory to growth-promoting effects. |
| Q52629172 | IRE1α-XBP1 inhibitors exerted anti-tumor activities in Ewing's sarcoma. |
| Q58565355 | Identification of driver genes associated with chemotherapy resistance of Ewing's sarcoma |
| Q37706134 | In silico and in vitro drug screening identifies new therapeutic approaches for Ewing sarcoma |
| Q47703632 | Inhibition of the oncogenic fusion protein EWS-FLI1 causes G2-M cell cycle arrest and enhanced vincristine sensitivity in Ewing's sarcoma. |
| Q28284358 | Intercohort gene expression co-analysis reveals chemokine receptors as prognostic indicators in Ewing's sarcoma |
| Q39239580 | Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma |
| Q37888461 | Metastatic soft tissue sarcoma chemotherapy: an opportunity for personalized medicine |
| Q58792269 | MicroRNA‑34b promotes proliferation, migration and invasion of Ewing's sarcoma cells by downregulating Notch1 |
| Q37300040 | Molecular abnormalities in Ewing's sarcoma |
| Q39793825 | Molecular characterization of commonly used cell lines for bone tumor research: a trans-European EuroBoNet effort |
| Q37301315 | Notch signaling in pediatric malignancies |
| Q39823354 | Pathobiologic Markers of the Ewing Sarcoma Family of Tumors: State of the Art and Prediction of Behaviour |
| Q36251549 | Pharmacogenomics and cancer stem cells: a changing landscape? |
| Q36924325 | Primary intracranial soft tissue sarcomas in children, adolescents, and young adults: single institution experience and review of the literature |
| Q47616563 | Protein phosphatase 1 regulatory subunit 1A in ewing sarcoma tumorigenesis and metastasis |
| Q28079316 | Recent advances in targeted therapy for Ewing sarcoma |
| Q30315828 | Receptor tyrosine kinase gene expression profiles of Ewing sarcomas reveal ROR1 as a potential therapeutic target in metastatic disease |
| Q38458016 | Role of genetic and molecular profiling in sarcomas |
| Q89944036 | SHH Signaling Pathway Drives Pediatric Bone Sarcoma Progression |
| Q47710977 | Sensitizing Ewing sarcoma to chemo- and radiotherapy by inhibition of the DNA-repair enzymes DNA protein kinase (DNA-PK) and poly-ADP-ribose polymerase (PARP) 1/2. |
| Q36011879 | Targeted therapy in Ewing sarcoma |
| Q41303735 | Targeting the p53 Pathway in Ewing Sarcoma. |
| Q60035696 | Therapeutic Targeting of KDM1A/LSD1 in Ewing Sarcoma with SP-2509 Engages the Endoplasmic Reticulum Stress Response |
| Q39465507 | miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy |
Search more.